Legal Issues Related to Rare Diseases

The absence of lawful controls on treating the uncommon rare diseases in numerous nations in the world, because of patients and their families are getting affected with various diseases obstructions when requesting for professional help. The first country to pass and approve the Orphan Drug Act in USA, followed by Japan in 1993, and eventually the European Union in 2000. The absence of a special International Disease Classification about disease leading to the IDC blocks the usage of a framework for the patients who are experiencing these diseases in the world. The main motto is to focus on rare diseases from the aspect of acceptable strategies or unsatisfactory social results is of critical need. 

  • Regulations on rare diseases
  • Ethical issues

Related Conference of Legal Issues Related to Rare Diseases

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs

(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 18-19, 2018

EuroSciCon Conference on Bacteriology

Paris, France

Legal Issues Related to Rare Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in